SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I - Tender offer statement by Issuer [amend]
SEC Accession No. 0001193125-11-319996
Filing Date
2011-11-22
Accepted
2011-11-22 17:05:05
Documents
3
Filing Date Changed
2011-11-22

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE TO d260406dsctoia.htm SC TO-I/A 34720
2 PRESS RELEASE, DATED NOVEMBER 22, 2011 d260406dex99a5iii.htm EX-99.(A)(5)(III) 32526
3 GRAPHIC g260406g05a10.jpg GRAPHIC 13565
  Complete submission text file 0001193125-11-319996.txt   87936
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799 (805)313-1762
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799 (805)313-1762
AMGEN INC (Subject) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A | Act: 34 | File No.: 005-34640 | Film No.: 111222524
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1